Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel

Journal of Biomedical Nanotechnology

Volumn 8, Issue 1, 2012, Pages 19-28

  Agrawal, R ^a   Shanavas, A ^a   Yadav, S ^a   Aslam, M ^a   Bahadur, D ^a   Srivastava, R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Docetaxel; Layer by layer self assembly; PLGA nanoparticles; Polyelectrolyte coatings; Sustained release

Indexed keywords

BREAST CANCER; CELL VIABILITY; CONTROLLED RELEASE; CYTOCOMPATIBILITY; DOCETAXEL; DRUG DELIVERY CARRIER; HYDRODYNAMIC DIAMETER; HYDROPHOBIC DRUG; IN-VITRO; LAYER BY LAYER; LAYER BY LAYER SELF ASSEMBLY; NANOPARTICLE SYSTEMS; PLGA NANOPARTICLES; POLY LACTIC ACID; POLYMERIC NANOPARTICLES; SELF-ASSEMBLY TECHNIQUE; SEM AND TEM; SIZE RANGES; SMALL MOLECULES; SUSTAINED RELEASE; THERAPEUTIC EFFICIENCY;

BIODEGRADABLE POLYMERS; COATINGS; DRUG DELIVERY; DRUG PRODUCTS; LACTIC ACID; POLYELECTROLYTES; POLYETHYLENE GLYCOLS; SELF ASSEMBLY;

NANOPARTICLES;

DOCETAXEL; DRUG CARRIER; NANOPARTICLE; POLYELECTROLYTE COATED POLYMERIC NANOPARTICLE; POLYETHYLENEIMINE; POLYGLACTIN; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; DRUG COATING; DRUG RELEASE; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE;

ANIMALS; CELL LINE; CELL SURVIVAL; DRUG CARRIERS; FIBROBLASTS; LACTIC ACID; MICE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; POLYMERS; SODIUM CHLORIDE; SONICATION; TAXOIDS;

EID: 84861470972     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1355     Document Type: Article

References (32)

1. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Shin, Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310 (2008).
2. P. Couvreur, C. Dubernet, and F. Puisieux, Controlled drug delivery with nanoparticles: Current possibilities and future trends. Eur. J. Pharm. Biopharm. 41, 2 (1995).
3. F. D. Jaeghere, E. Doelker, and R. Gurny, Encyclopedia of controlled drug delivery, edited by E. Mathiowitz, John Wiley & Sons, New York (1999), p. 641.
4. M. S. Shive and J. M. Anderson, Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev. 28, 5 (1997).
5. L. S. Nair and C. T. Laurensin, Biodegradable polymers as biomaterials. Progress Poly Sci. 32, 762 (2007).
6. A. S. Mikhail and C. Allen, Block copolymer micelles for delivery of cancer therapy: Transport at the whole body tissue and cellular levels. J. Control Release 138, 214 (2009).
7. R. Gref, Y. Minanitake, M. T. Perachhia, V. Trubetskoy, V. Torchilin, and R. Langer, Biodegradable long-circulating polymeric nanospheres. Science 263, 1600 (1994).
8. A. S. Hassan, A. Sapin, A. Lamprecht, E. Emond, F. E. Ghazouani, and P. Maincent, Composite microparticles with in vivo reduction of the burst release effect. Eur. J. Phar. and Biopharm. 73, 337(2009).
9. H. Ai, S. A. Jones, and Y. M. Lvov, Biomedical applications of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles. Cell Biochemistry and Biophysics Rev. 39, 23 (2003).
10. J. E. Wong, A. K. Gaharwar, D. M. Schulte, D. Bahadur, and W. Richtering, Layer-by-layer assembly of magnetic nanoparticles shell on thermoresponsive microgel core. J. Magn. & Magnetic Mater. 311, 219 (2007).
11. A. Joshi, R. Keerthiprasad, R. D. Jayant, and R. Srivastava, Nano-in- micro alginate based hybrid particles. Carbohydrate Polymers 81, 790 (2010).
12. K. A. L. Williamson and C. Fenton, Docetaxel: A review of its use in metastatic breast cancer. Drugs 65, 2513 (2005).
13. A. Lamprecht, N. Ubrich, P. M. Hombreiro, C. M. Lehr, M. Hoffman, and P. Maincent, Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int. J. Pharm. 196, 177 (2000).
14. I. D. Rosca, F. Watari, and M. Uo, Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J. Control Release 99, 271 (2004).
15. F. Esmaeili, M. H. Nasr, M. R. Malekshahi, N. Samadi, F. Atyabi, and R. Dinavard, Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles, Nanomedicine: Nanotechnology. Biology and Medicine 3, 161 (2007).
16. M. Bivas-Benita, S. Romeijn, H. E. Junginger, and G. Borchard, PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur. J. Pharm. Biopharm. 58, 1 (2004).
17. B. Chu and T. Liu, Characterization of nanoparticles by scattering techniques. J. Nanoparticle Res. 2, 29 (2000).
18. A. Sze, D. Erickson, L. Ren, and D. Li, Flow Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow. J. Colloid Interface Science 261, 402 (2003).
19. K. S. Soppinath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices. J. Control Release 70, 1 (2001).
20. M. Chrony, I. Fishbein, H. D. Danenberg, and G. Golomb, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics. J. Control Release 83, 389 (2002).
21. J. Panyam, D. Williams, A. Dash, D. L. Pelecky, and V. Labhasetwar, Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J. Pharm. Sci. 93, 1804 (2004).
22. V. Vichai and K. Kirtikara, Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols 1, 1112 (2006).
23. M. Chrony, I. Fishbein, H. D. Danenberg, and G. Golomb, Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods, J. Control Release 83, 401 (2002).
24. M. Madeli, R. Haag, and Z. Zarnegar, Effect of the shell on the transport properties of poly(glycerol) and Poly(ethylene imine) nanoparticles, J. Nanoparticle Research 9, 1057 (2007).
25. C. Yilmaz, H. B. Woo, S. Gebrekidan, S. Ahmed, P. Patrick, and D. Luca, Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. J. Control Release 60, 279 (1999).
26. L. Wang, J. Dong, J. Chen, J. Eastoe, and X. Li, Design and optimization of a new self-nanoemulsifying drug delivery systems. J. Colloid Interface Sci. 330, 443 (2009).
27. M. J. Santander-Ortega, A. B. Jódar-Reyes, N. Csaba, D. Bastos- González, and J. L. Ortega-Vinuesa, Colloidal stability of Pluronic F68-coated PLGA nanoparticles: A variety of stabilisation mechanisms, J. Colloid Interface Sci. 302, 522 (2006).
28. H. Murakami, Y. Kawashima, T. Niwa, T. Hino, H. Takeuchi, and M. Kobayashi, Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(dl-lactide-co- glycolide) nanoparticle. Int. J. Pharm. 149, 43 (1997).
29. R. M. Mainrades and R. C. Evangelista, PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int. J. Pharm. 290, 137 (2005).
30. H. Fessi, F. Puisieux, J. P. Devissageut, N. Ammoury, and S. Benita, Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55, R1 (1989).
31. T. Trimaille, C. Pichot, and T. Delair, Surface functionalization of poly(d,l-lactic acid) nanoparticles with poly(ethylenimine) and plasmid DNA by the layer-by-layer approach. Colloids and Surface A: Physicochem. Eng. Aspects 221, 39 (2003).
32. S. Patnaik, M. Arif, A. Pathak, N. Singh, and K. C. Gupta, PEI-Alginate nanocomposites: Efficient non-viral vectors for nucleic acids. Int. J. Pharmacol 385, 194 (2009).